Assure Holdings Corp. IONM

0.00 0.00 NaN as of 24 Sep
Market cap
$330.0K
P/E
0.0×
Growth Flags show if company had growth for consecutive years

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 12.14%

Capital & Financial Ratios

Market Cap 0.33
Revenue 0.08
Net Income (20.90)
Free Cash Flow (1.62)
Net Debt 13.66
Current Ratio 0.20
Debt/Equity (0.73)
P/E ratio 0.00
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth (19.33%)
This Y EPS Growth —
Next Y EPS Growth —
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2021 2022 2023 Q'24
Cash 4 1 0 0
Receivables 28 15 4 3
Inventory — — — —
Other 6 7 3 1
38 23 7 5
2021 2022 2023 Q'24
Payables 2 3 7 8
ST’ Debt 1 1 14 14
Other 1 0 0 0
4 5 22 24
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — (52.81%) (58.33%)
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue

Mar Jun Sep Dec Year
’26 0 0 — — —
’23 0 0 0 0 0
’22 5 2 0 — 0
’21 5 6 9 10 29
’20 4 (11) 4 6 4
’19 — — — — 18
’18 — — — — 11
in millions of $ · fiscal quarters ending in the months shown
value withheld pending a data check

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (1) 0 — — —
’23 0 (2) (2) 0 (5)
’22 (2) (1) (2) (2) (7)
’21 (2) (4) (3) (4) (13)
’20 (1) 0 (2) (1) (3)
’19 — — — (4) (4)
’18 — — — — 1
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 1 0 — — —
’23 0 (2) (2) 0 (5)
’22 (2) (1) (2) (2) (7)
’21 (2) (4) (3) (4) (13)
’20 (1) 0 (2) (1) (4)
’19 — — — (4) (4)
’18 — — — — 1
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (9.71) (0.50) — — —
’23 (73.56) (29.32) (22.12) (0.22) (109.71)
’22 (68.34) (133.09) (32.37) (486.28) (720.50)
’21 (35.97) (35.97) 2.08 (10.79) (86.33)
’20 (21.40) (665.47) (53.96) (24.83) (737.41)
’19 — — — — 107.91
’18 — — — — 7.07
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
— — — 1,800.00 1,800.00 1,782.00 919.62 1,648.80 84.64 3.60

Analyst estimates 2024–2026

Powerpack
Low Price
— — — 6,300.00 6,205.14 4,150.62 3,870.00 4,086.00 2,934.00 160.75
High Price
— — — — — — 91 134 127 95
Employees
— — 0 0 0 0 0 0 0 0
Revenue/Emp
— — 5 13 11 18 4 29 0 0
Revenue
— — 82.76% 82.12% 73.28% 72.05% (124.52%) 50.95% (437.58%) (860.39%)
Gross Margin
— — 3 (8) 4 4 (17) (4) (23) (22)
EBT
— — 63.95% (60.70%) 32.97% 19.87% (488.68%) (12.28%) (4,811.25%) (8,699.22%)
EBT Margin
— — 3 0 3 3 (15) (3) (30) (26)
Net Income
— — 0 0 0 1 1 1 7 0
Depreciation
— — 3.05 1.90 30.64 928.01 175.32 895.46 11.27 1.07
Revenue/Sh
— — 1.78 (0.66) 8.93 125.90 (737.41) (86.33) (720.50) (109.71)
Earnings/Sh
— — 0.42 (0.19) 1.68 (221.36) (158.41) (410.21) (177.37) (21.21)
Cash Flow/Sh
— — 0.00 0.00 0.00 (2.51) (15.87) 0.00 (1.91) 0.00
Capex/Sh
— — 0.42 (0.19) 1.68 (223.87) (174.28) (410.21) (179.28) (21.21)
Free CF/Sh
— — 1.65 0.29 16.28 526.96 955.67 888.22 130.74 (64.49)
Book Value/Sh
— — 2 7 0 0 0 0 0 0
Shares
— — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PE Ratio
— — 0.00 0.00 0.00 0.00 10.57 2.17 8.95 4.64
PS Ratio
— — 0.00 0.00 0.00 0.00 1.94 2.19 0.77 0.00
PB Ratio
— — 0.00 0.00 0.00 0.00 11.13 2.53 35.31 60.08
EV/Sales
— — 0.00 0.00 0.00 0.00 (13.76) (5.39) (2.22) (2.99)
EV/FCF
— — 1 (1) 1 (4) (3) (13) (7) (5)
Op' Cash Flow
— — 0 0 0 0 0 — 0 —
Capex
— — 1 (1) 1 (4) (4) (13) (7) (5)
FCF
— — 3 13 16 22 17 34 18 (15)
Working Cap'
— — 0 0 1 10 6 14 13 14
Total Debt
— — 0 0 0 10 2 10 12 14
Net Debt
— — 3 2 6 10 19 29 5 (15)
Sh' Equity
— — 23.52% (175.29%) 29.80% 8.27% (38.54%) (6.72%) (82.89%) (164.20%)
ROA
— — 0.00% 0.00% 0.00% 7.30% (47.83%) (3.38%) (77.04%) 0.00%
ROIC
— — 118.69% (196.42%) 82.20% 34.27% (102.73%) (11.44%) (174.96%) 528.43%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2023 · latest quarter Jun 2024

Assure Holdings Corp. peers in Medical Care Facilities

All 55 Medical Care Facilities stocks →

Assure Holdings Corp. (IONM) Latest News

News by impact score

Fine-tune

6 Sep

3

Assure Holdings Corp. amends its Convertible Note Exchange Offer, changing the consideration and extending the deadline. The amendment to the Convertible Note Exchange Offer may moderately influence the company's financial performance and competitive positioning.

5 Aug

3

Assure Holdings Corp. extends the expiration date of its exchange offer relating to its Convertible Debentures, now set to expire on August 16, 2024. The extension of the exchange offer may moderately influence the company's financial performance and market sentiment.

22 Jul

3

Assure Holdings Corp. extends expiration date of exchange offer for its Convertible Debentures until July 26, 2024. The extension of the exchange offer may moderately influence the company's financial performance and investor sentiment.

3 Jul

3

Assure Holdings Corp. announces a reverse stock split at a ratio of 18:1 to maintain listing on NASDAQ. The reverse stock split is expected to have a moderately noticeable influence on the company's financial performance and market sentiment.

28 May

3

Assure Holdings received a delinquency notice from Nasdaq for not filing quarterly report on time. The delinquency notice could moderately impact the company's financial performance and market sentiment.

17 May

3

Assure Holdings Corp. reschedules joint corporate update call with Danam for May 22, 2024 at 4:00 PM Eastern Time. The rescheduled corporate update call may moderately influence investor sentiment and future operational developments.

16 May

3

Assure Holdings Corp. (IONM) will remain listed on the Nasdaq Capital Market after receiving an extension to regain compliance with listing requirements. The extension granted by Nasdaq may have a moderately noticeable influence on Assure Holdings Corp.'s future performance and market sentiment.

3

Assure Holdings Corp. approved an increase in authorized capital from 9,000,000 to 250,000,000 shares of common stock. The increase in authorized capital may have a moderately noticeable influence on the company's financial flexibility and strategic plans.

3

Assure Holdings Corp. closed a $6 million underwritten public offering of 5,000,000 shares of common stock. The offering will have a moderately noticeable influence on the company's financial performance and general corporate purposes.

13 May

3

Assure Holdings Corp. to host corporate update call with Danam on May 16, 2024 at 4:00 PM Eastern Time. The joint corporate update call may moderately influence key areas such as financial performance and competitive positioning.

6 May

3

Assure Holdings Corp. reminds stockholders to vote for proposed increase in authorized shares. The outcome of the vote on the increase in authorized shares could have a moderately noticeable influence on the company's future capital structure.

28 Mar

4

Assure Holdings Corp. closed the sale of certain assets to MPOWERHealth for up to $4.5 million. The sale of assets to MPOWERHealth is a significant move that could alter Assure Holdings Corp.'s trajectory and market sentiment.

11 Mar

3

Assure Holdings sells assets to MPOWERHealth. The sale of assets may moderately influence Assure Holdings Corp.'s financial performance and competitive positioning.

12 Feb

4

Assure Holdings Corp. announces business combination with Danam Health, Inc. The business combination with Danam Health, Inc. is a significant strategic move that could alter Assure Holdings Corp.'s trajectory and investor sentiment.

2 Nov

3

Assure Holdings granted extension by Nasdaq to regain compliance with stockholders' equity requirement. Extension granted by Nasdaq may moderately influence Assure Holdings Corp.'s future financial performance and market positioning.

19 Sep

4

Assure Holdings Corp. is exploring strategic alternatives to maximize shareholder value. The exploration of strategic alternatives, including potential acquisition or merger, could significantly impact the company's future trajectory and market performance.

7 Sep

3

Assure Holdings Corp. to participate in 1x1 meetings at H.C. Wainwright 25th Annual Global Investment Conference. Participation in the conference may moderately influence the company's financial performance and competitive positioning.

15 Aug

4

Assure Holdings Corp. reports second quarter 2023 financial results, highlighting challenges in reimbursement from insurance payors. The significant impact on future performance is expected due to the ongoing challenges in reimbursement and the company's strategic moves for growth and acquisitions.

3 Aug

4

Assure Holdings Corp. acquires assets of Innovation Neuromonitoring, LLC for $1.2 million, expects to increase annual number of cases by more than 3,000. The acquisition of assets and expected increase in cases by more than 3,000 surgeries annually is a significant strategic move that could have a major impact on Assure Holdings Corp.'s future performance and market positioning.

27 Jun

4

Assure Holdings Corp. signs Diagnostics Services Agreement with Neurovative Diagnostics to expand EEG services. The agreement with Neurovative Diagnostics is expected to significantly impact Assure Holdings Corp.'s future by expanding its service offerings and market reach.

26 Jun

4

Assure Holdings Corp. signs LOI to purchase assets of Innovation Neuromonitoring, LLC for $1.2 million in cash and equity transaction. The acquisition of assets from Innovation Neuromonitoring is expected to significantly increase the annual number of cases by more than 3,000, impacting Assure Holdings Corp.'s future performance.

1 Jun

3

Assure Holdings Corp. to present at upcoming conferences in June. The presentation at conferences may moderately influence key areas such as investor sentiment and market performance.

12 May

4

Assure Holdings Corp. priced a $6 million underwritten public offering of 5,000,000 shares of common stock. The public offering of $6 million is a significant move that could impact the company's financial performance and market positioning.

3

Assure Holdings Corp. sets conference call for first quarter financial results on May 16, 2023. The conference call may moderately influence investor sentiment and financial performance.

10 May

3

Assure Holdings Corp. reports preliminary first quarter 2023 financial results, showing a decline in revenue and net loss. The financial results and business highlights mentioned in the article are expected to moderately influence the company's financial performance and competitive positioning.

8 May

4

Assure Holdings Corp. expects $3.3 million federal tax refund for Employee Retention Credit and has a multi-million dollar reimbursement lawsuit set for jury trial in July. The potential impact of receiving a significant tax refund and the outcome of a multi-million dollar lawsuit could significantly alter the company's trajectory and investor sentiment.

5 May

3

Assure Holdings Corp. performed its first neuromonitoring case in Montana. The expansion into a new market like Montana may moderately influence the company's growth and development.

stockrow.com/IONM · Data as of Jun 30, 2024 · For information only; not investment advice. · © 2026 stockrow.com